Ace the Case: A 42-Year-Old Woman With Anemia and Elevated Serum Total Protein

Ace the Case: A 42-Year-Old Woman With Anemia and Elevated Serum Total Protein is organized by Penn State College of Medicine, RedMedEd, Multiple Myeloma Research Foundation (MMRF).

Dates:
This enduring material is approved for 1 year from the date of original release, September 22, 2020 to September 22, 2021. 

Accreditation:
Penn State College of Medicine designates this enduring material for 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn 0.25 Maintenance of Certification (MOC) points in the American Board of Internal Medicine’s (ABIM) MOC program. Participants who opt in will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC points.

Activity Description:
This educational activity will utilize a case study to discuss minimal residual disease measurement and treatment options for newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant (ASCT). 

Learning Objective:
Upon successful completion of this educational activity, participants should be better able to evaluate emerging data regarding the optimal timing and approach to high-dose melphalan (HDM)-ASCT based on minimal residual disease (MRD) status